
浏览全部资源
扫码关注微信
1.贵州中医药大学 第一附属医院,贵阳 550001
2.贵州中医药大学,贵阳 550001
3.安顺市普定县中医医院,贵州 安顺 562100
刘国雄,硕士,副主任医师,从事中西医结合急症医学临床诊疗工作,E-mail:eroero121@126.com
陈杨,副主任医师,从事中西医结合重症医学临床诊疗工作,E-mail:368cy368@163.com
收稿日期:2020-09-15,
网络出版日期:2020-11-19,
纸质出版日期:2021-03-05
移动端阅览
刘国雄,匡桥贵,喻欣荷等.加味大承气汤治疗湿热蕴结型高脂血症性急性胰腺炎的疗效及作用机制[J].中国实验方剂学杂志,2021,27(05):91-97.
LIU Guo-xiong,KUANG Qiao-gui,YU Xin-he,et al.Therapeutic Effect and Mechanism of Modified Da Chengqitang in Treating Hyperlipidemic Acute Pancreatitis with Damp Heat Accumulation Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(05):91-97.
刘国雄,匡桥贵,喻欣荷等.加味大承气汤治疗湿热蕴结型高脂血症性急性胰腺炎的疗效及作用机制[J].中国实验方剂学杂志,2021,27(05):91-97. DOI: 10.13422/j.cnki.syfjx.20210225.
LIU Guo-xiong,KUANG Qiao-gui,YU Xin-he,et al.Therapeutic Effect and Mechanism of Modified Da Chengqitang in Treating Hyperlipidemic Acute Pancreatitis with Damp Heat Accumulation Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(05):91-97. DOI: 10.13422/j.cnki.syfjx.20210225.
目的
2
观察加味大承气汤治疗湿热蕴结型高脂血症性急性胰腺炎的疗效,探讨作用机制。
方法
2
将贵州中医药大学第一附属医院收治的110例湿热蕴结型高脂血症性急性胰腺炎患者随机分为对照组和观察组,各55例,两组患者均给予低分子肝素钙、胰岛素及前列地尔注射液等常规治疗。对照组在常规治疗基础上给予化滞柔肝颗粒;观察组在常规治疗基础上给予加味大承气汤治疗。治疗7 d,比较两组患者的临床疗效、中医证候评分、胃肠功能恢复情况、急性胰腺炎床旁指数(BISAP)评分、急性生理与慢性健康状况Ⅱ(APACHEⅡ)评分、炎性因子[肿瘤坏死因子(TNF)-
α
,白细胞介素-6(IL-6),C反应蛋白(CRP)]水平,氧化应激[丙二醛(MDA),氧化型谷胱甘肽(GSSG),总抗氧化能力(T-AOC)]指标水平,总胆固醇(TC),甘油三酯(TG),高、低密度脂蛋白胆固醇(HDL-C,LDL-C)血脂指标,安全性评价。
结果
2
观察组临床疗效明显优于对照组(
Z
=3.353,
P
<
0.05),且总有效率52/55(94.55%)高于对照组的41/55(74.55%)(
χ
2
=8.419,
P
<
0.01);与本组治疗前比较,治疗后两组患者腹痛、大便不通、胸闷、发热评分均明显降低,且观察组腹痛、大便不通、胸闷、发热评分低于对照组(
P
<
0.05);观察组的胃管留置时间、排气时间、排便时间和肠鸣音恢复时间低于对照组(
P
<
0.05)。与本组治疗前比较,治疗后两组患者BISAP,APACHEⅡ评分均明显降低,且观察组BISAP,APACHEⅡ评分低于对照组(
P
<
0.05)。与本组治疗前比较,治疗后两组患者血清TNF-
α
,IL-6和CRP水平均明显降低,且观察组血清TNF-
α,
IL-6和CRP水平低于对照组(
P
<
0.05)。与本组治疗前比较,治疗后两组患者血清MDA,GSSG水平均明显降低,T-AOC明显升高,且观察组血清MDA,GSSG水平低于对照组,T-AOC水平高于对照组(
P
<
0.05)。治疗后观察两组TC,TG,LDL-C水平降低,HDL-C水平升高,且TC,TG,LDL-C水平低于对照组,HDL-C水平高于对照组(
P
<
0.05)
。
结论
2
加味大承气汤治疗湿热蕴结型高脂血症性急性胰腺炎临床疗效确切,可改善中医证候和患者症状,降低炎性因子,抑制机体氧化应激,改善血脂水平,且具有较好的安全性,值得临床推广应用。
Objective
2
To explore the efficacy and mechanism of modified Da Chengqitang in treating hyperlipidemic acute pancreatitis (HLAP) with damp heat accumulation syndrome.
Method
2
A total of 110 patients with HLAP with damp heat accumulation syndrome treated at our hospital were randomly divided into control group and observation group, with 55 cases in each group, both groups were treated with low molecular weight heparin calcium, insulin and alprostadil injection. Control group was given Huazhironggan granules in addition to the basic therapy, while observation group was given modified Da Chengqitang in addition to the basic therapy. After 7 days, the clinical efficacy, traditional Chinese medicine (TCM) syndrome score, gastrointestinal function recovery, acute pancreatitis bedside index (BISAP), acute physiology and chronic health status Ⅱ (APACHE Ⅱ), inflammatory factors, such as tumor necrosis factor-
α
(TNF-
α
), interleukin-6 (IL-6) and C-reactive protein (CRP), oxidative stress, such as malondialdehyde (MDA), oxidized glutathione (GSSG), total antioxidant capacity (T-AOC), total cholesterol (TC), triglyceride (TG), high and low density lipoprotein (HDL-C, LDL-C) blood lipid indicators and safety were evaluated.
Result
2
The clinical efficacy of observation group was significantly better than that of control group (
Z
=3.353,
P
<
0.05), and the total effective rate of observation group was 94.55%, which was higher than 74.55% of control group (
χ
2
=8.419,
P
<
0.01). After treatment, the scores of abdominal pain, stool obstruction, chest tightness and fever in observation group were significantly lower than those of control group (
P
<
0.05). The gastric tube indwelling exhaust time, defecation time and recovery time of bowel sounds in observation group were significantly lower than those of control group (
P
<
0.05). The scores of BISAP and APACHE Ⅱ in two groups were significantly decreased, and the BISAP and APACHE Ⅱ scores of observation group were lower than control group (
P
<
0.05). After treatment, the serum levels of TNF-
α
, IL-6 and CRP in observation group were significantly lower than those in control group. The levels of serum MDA, GSSG in two groups were significantly decreased, whereas the T-AOC level was significantly increased; and the level of serum MDA, GSSG observation group was lower than control group, while the T-AOC level was higher than control group (
P
<
0.05). After treatment, the levels of TC, TG and LDL-C in two groups were decreased, while the level of HDL-C was increased, the levels of TC, TG and LDL-C in observation group were lower than those in control group, and the HDL-C was higher than that control group (
P
<
0.05).
Conclusion
2
modified Da Chengqitang has a definite clinical efficady in treating HLAP with damp heat accumulation syndrome, and can alleviate TCM syndrome and patient symptoms, reduce inflammatory factors, inhibit oxidative stress of the body. It has a good safety, and is worthy of clinical application.
陶丽娟 , 刘小静 , 王彩芹 , 等 . 中医通里攻下法联合早期微生态肠内营养对急性胰腺炎患者炎症反应及预后的影响 [J]. 现代中西医结合杂志 , 2020 , 29 ( 24 ): 2699 - 2702 .
钟瑞 , 严永峰 , 蒋鑫 , 等 . 急性胰腺炎合并代谢综合征的临床特征及预后影响因素分析 [J]. 临床肝胆病杂志 , 2020 , 36 ( 8 ): 1794 - 1798 .
谢蕾 , 刘航 , 申洋 , 等 . 重症急性胰腺炎并发感染的危险因素及对机体免疫水平的影响 [J]. 中华胰腺病杂志 , 2020 , 20 ( 4 ): 283 - 287 .
郭晓芳 , 尤勇 , 朱章华 . 高脂血症性重症急性胰腺炎患者血脂水平对血浆置换反应性因素及预后分析 [J]. 医学研究生学报 , 2020 , 33 ( 4 ): 399 - 403 .
张杰 , 沈洪章 , 杨传春 , 等 . 高脂血症性急性、胆源性胰腺炎的临床对比 [J]. 中国继续医学教育 , 2020 , 12 ( 13 ): 102 - 104 .
张薇 , 王晓戎 , 徐茂奇 , 等 . 老年急性胰腺炎患者发病影响因素及生长抑素干预作用机制 [J]. 中国老年学杂志 , 2020 , 40 ( 17 ): 3656 - 3658 .
冯萍萍 , 徐燕芳 , 童宝燕 , 等 . 柴芍承气汤对不同时期高脂血症性急性胰腺炎患者淀粉酶、血脂及炎性因子的影响 [J]. 中国中医药科技 , 2020 , 27 ( 1 ): 15 - 18 .
张晓敏 , 尚福泰 . 重症急性胰腺炎继发胰腺感染的危险因素分析及应对 [J]. 湖南师范大学学报:医学版 , 2020 , 17 ( 4 ): 73 - 76 .
冯勇 , 谭冬梅 , 李彬 , 等 . 柴芩承气汤对急性重症胰腺炎的疗效观察及部分机制 [J]. 世界中医药 , 2019 , 14 ( 11 ): 2940 - 2944 .
成向进 , 林朝亮 , 朱红林 , 等 . 大承气汤加味干预急性胰腺炎合并腹腔高压患者的临床研究 [J]. 中国中医急症 , 2020 , 29 ( 2 ): 253 - 255,259 .
杜奕奇 , 陈其奎 , 李宏宇 , 等 . 中国急性胰腺炎诊治指南(2019年,沈阳) [J]. 临床肝胆病杂志 , 2019 , 35 ( 12 ): 2706 - 2711 .
张声生 , 李慧臻 . 急性胰腺炎中医诊疗专家共识意见(2017) [J]. 中华中医药杂志 , 2017 , 32 ( 9 ): 4085 - 4088 .
中华中医药学会脾胃病分会 . 急性胰腺炎中医诊疗专家共识意见(2017) [J]. 临床肝胆病杂志 , 2017 , 33 ( 11 ): 2052 - 2057 .
中华人民共和国卫生部 . 中药新药临床研究指导原则 [M]. 北京 : 中国医药科技出版社 , 2002 : 135 - 137 .
吕魁 . BISAP评分系统、NLR对急性胰腺炎预后的预测价值 [J]. 肝胆外科杂志 , 2018 , 26 ( 6 ): 437 - 440 .
陈燕昌 , 黄鹤光 , 陈大良 , 等 . 重症急性胰腺炎APACHEⅡ评分的应用价值 [J]. 中国普通外科杂志 , 2002 , 11 ( 3 ): 139 - 141 .
安文慧 , 杨婧 , 何旭昶 , 等 . 高脂血症性急性胰腺炎的临床特征及其与脂代谢的关系 [J]. 临床肝胆病杂志 , 2020 , 36 ( 4 ): 860 - 864 .
李丹 , 刘凤奎 , 王国兴 . 高脂血症性急性胰腺炎和胆源性急性胰腺炎的临床特点分析 [J]. 临床和实验医学杂志 , 2019 , 18 ( 19 ): 2066 - 2071 .
冯小鹏 , 杨国华 , 张艳玲 . 甘油三酯水平与高脂血症性急性胰腺炎严重程度的关系 [J]. 中国临床实用医学 , 2019 , 10 ( 6 ): 18 - 19,21 .
谢学文 , 费书珂 . 高脂血症性急性胰腺炎病因的研究进展 [J]. 国际外科学杂志 , 2020 , 47 ( 5 ): 342 - 346 .
陈辉 , 兰涛 , 张培君 , 等 . BISAP、Ranson和APACHE Ⅱ评分系统对高脂血症性急性胰腺炎患者病情和预后的评估价值 [J]. 现代生物医学进展 , 2020 , 20 ( 2 ): 361 - 365,396 .
周琳婧 , 李昊 , 张蕾 , 等 . 血液灌流联合床旁连续性血液净化治疗高脂血症性重症急性胰腺炎的临床研究 [J]. 中国现代普通外科进展 , 2019 , 22 ( 10 ): 836 - 838 .
邓丽芸 , 肖涌 , 刘劼 , 等 . 低分子肝素钙联合胰岛素治疗重症高脂血症性急性胰腺炎的疗效及对血清氧化应激和炎症因子的影响 [J]. 广西医科大学学报 , 2019 , 36 ( 2 ): 209 - 213 .
郇义超 , 赵佳 . 加味大承气汤对急性胰腺炎模型大鼠血清炎症因子及细胞凋亡的影响 [J]. 中国中医急症 , 2017 , 26 ( 7 ): 1152 - 1155 .
易琼 , 戴飞跃 , 郭志华 , 等 . 加味大承气汤保留灌肠辅助治疗重症急性胰腺炎并发急性呼吸窘迫综合征腑实热结证45例临床观察 [J]. 中医杂志 , 2019 , 60 ( 19 ): 1657 - 1662 .
中华中医药学会脾胃病分会 , 刘凤斌 , 胡玲 , 等 . 消化系统常见病急性胰腺炎中医诊疗指南(基层医生版) [J]. 中华中医药杂志 , 2020 , 35 ( 4 ): 1906 - 1913 .
孙文杰 , 陈亚峰 , 高磊 , 等 . 中药治疗急性胰腺炎机制的研究进展 [J]. 中成药 , 2019 , 41 ( 8 ): 1932 - 1935 .
郭澜 , 袁鑫 , 王美峤 , 等 . 枳实薤白桂枝汤应用研究进展 [J]. 河北中医 , 2019 , 41 ( 6 ): 942 - 946 .
韩四九 . 中药当归的炮制及应用药理 [J]. 北方药学 , 2019 , 16 ( 11 ): 194 - 195 .
姚雪 , 吴国真 , 赵宏伟 , 等 . 黄芩中化学成分及药理作用研究进展 [J]. 辽宁中医杂志 , 2020 , 47 ( 7 ): 215 - 220 .
聂欣 , 成颜芬 , 王琳 , 等 . 桃红四物汤化学成分、药理作用、临床应用的研究进展及质量标志物的预测分析 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 4 ): 226 - 234 .
莫琼 , 郝二伟 , 覃文慧 , 等 . 平性活血化瘀中药物质基础与药理作用的研究进展 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 1 ): 205 - 216 .
0
浏览量
14
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621